Drug profile

The FDA adverse-event record for Bovine Virus*5/Past M+Mh Lv/Lb

243 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Bovine Virus*5/Past M+Mh Lv/Lb. See the species affected, top reactions, and outcomes below.

243
adverse-event reports
86.8%
death-coded share
Cattle
most-reported species
190
Death - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
243
Total Reports
211
Deaths Reported
86.8%
Death Rate

Active Ingredients

Bovine Virus*5/Past M+Mh Lv/Lb

Administration Routes

SubcutaneousUnknownSubmucosal

Species Affected

Cattle 243

Most Affected Breeds

Cattle (other) 118
Crossbred Bovine/Cattle 44
Aberdeen Angus 38
Red Angus 13
Holstein-Friesian also known as Holstein 8
Mixed (Cattle) 6
Cattle (unspecified) 4
Charolais 4
Simmental 2
Hereford cattle 2

Most Reported Reactions

Death 190
Lack of efficacy - NOS 125
Lack of efficacy (bacteria) - NOS 38
Respiratory signs 20
Found dead 13
NT - Abnormal necropsy finding NOS 11
Lack of efficacy (endoparasite NOS) 9
CULTURE/TITER DATA ABNORMAL 8
Anaphylaxis 8
Lack of efficacy (mycoplasma) - NOS 8
Necropsy performed 8
INEFFECTIVE, ANTIBIOTIC 6

Outcome Breakdown

Died
209 (42.8%)
Ongoing
133 (27.3%)
Recovered/Normal
93 (19.1%)
Outcome Unknown
44 (9.0%)
Euthanized
7 (1.4%)
Recovered with Sequela
2 (0.4%)

Bovine Virus*5/Past M+Mh Lv/Lb Adverse Event Insights

243 reports name Bovine Virus*5/Past M+Mh Lv/Lb; 211 recorded a death outcome (86.8% of reported events, not a population-level mortality rate). Active ingredient: Bovine Virus*5/Past M+Mh Lv/Lb. Administration routes: Subcutaneous, Unknown, Submucosal.

By species: Cattle (243 reports). By breed: Cattle (other) (118), Crossbred Bovine/Cattle (44), Aberdeen Angus (38).

Leading clinical signs: Death (190), Lack of efficacy - NOS (125), Lack of efficacy (bacteria) - NOS (38), Respiratory signs (20). Outcome, 488 coded reports: Died leads at 42.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.